Expert Pitch

Rutgers Scholar Available to Discuss Concerning Trends of Suicidal Behavior Before and During COVID-19

Rutgers psychologist Edward Selby is available to comment on the need for greater awareness and prevention of suicidal behavior during COVID-19 pandemic.

“Suicidal behavior has been escalating in the United States over the last 20 years, and we saw a particularly sharp increase in suicide rates up to the start of this year,” said Selby, an associate professor of clinical psychology in the School of Arts and Sciences. “The pandemic has contributed to greater levels of stress, mental health conditions and substance use, and I worry the trajectory for suicide may worsen further.”

Selby leads the Emotion and Psychopathology Lab at Rutgers and is a core faculty member of the Institute for Health, Health Care Policy and Aging Research.

ABOUT RUTGERS INSTITUTE FOR HEALTH

Rutgers Institute for Health, Health Care Policy and Aging Research advances health and well-being through meaningful, rigorous and impactful research in the critical areas of behavioral health, health services, health disparities, health policy, health economics, pharmacoepidemiology, and aging research. 

Since its 1985 founding, the Institute has become nationally renowned for interdisciplinary and translational research. The Institute's 57,000 square foot facilities are home to six members elected to the National Academy of Medicine and 150 members representing over 30 schools, institutes, and units with adjunct members from 29 national and international universities.




Filters close

Showing results

110 of 4595
access_time Embargo lifts in 2 days
Embargo will expire: 20-Jan-2021 11:00 AM EST Released to reporters: 19-Jan-2021 5:35 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 20-Jan-2021 11:00 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 19-Jan-2021 4:45 PM EST
Rush researchers demonstrate success with new therapy for COVID-19
Rush University Medical Center

A new therapy developed by researchers at Rush University Medical Center is showing success as a way to prevent COVID-19 symptoms in mice.

Released: 19-Jan-2021 2:55 PM EST
Sequencing of wastewater useful for control of SARS-CoV-2
American Society for Microbiology (ASM)

Viral genome sequencing of wastewater can detect new SARS-CoV-2 variants before they are detected by local clinical sequencing, according to a new study reported in mBio, an open-access journal of the American Society for Microbiology.

Released: 19-Jan-2021 2:50 PM EST
COVID-19 virus triggers antibodies from previous coronavirus infections
Translational Genomics Research Institute (TGen)

The results of a study led by Northern Arizona University and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest the immune systems of people infected with COVID-19 may rely on antibodies created during infections from earlier coronaviruses to help fight the disease.

Released: 19-Jan-2021 2:05 PM EST
Loss of smell is the best sign of COVID-19
Aarhus University

Two international studies confirm that for the majority of patients with respiratory infections who lose the sense of smell, this is due to COVID-19.

Released: 19-Jan-2021 1:45 PM EST
Loneliness hits young people harder during lockdown
University of Copenhagen, Faculty of Health and Medical Sciences

Fear of losing your job, worrying about you or a loved one getting sick, and online meetups with family and friends you have not seen for months.

Released: 19-Jan-2021 1:25 PM EST
Spike proteins of SARS-CoV-2 relatives can evolve against immune responses
eLife

Scientists have shown that two species of seasonal human coronavirus related to SARS-CoV-2 can evolve in certain proteins to escape recognition by the immune system, according to a study published today in eLife.

Newswise: Hackensack Meridian’s John Theurer Cancer Center (JTCC) Observational Study Suggests Role for Hydroxycholorquine as Outpatient Treatment for COVID-19 Infection
Released: 19-Jan-2021 12:30 PM EST
Hackensack Meridian’s John Theurer Cancer Center (JTCC) Observational Study Suggests Role for Hydroxycholorquine as Outpatient Treatment for COVID-19 Infection
Hackensack Meridian Health

Paper published in BMC Infectious Diseases documents association between hydroxychloroquine exposure and reduced hospitalization rates in mildly symptomatic outpatients with COVID-19

Newswise: NAU-TGen study results show COVID-19 virus triggers antibodies from previous coronavirus infections
Released: 19-Jan-2021 11:30 AM EST
NAU-TGen study results show COVID-19 virus triggers antibodies from previous coronavirus infections
Northern Arizona University

A collaborative study shows COVID-19 virus triggers antibodies from previous coronavirus infections, such as the common cold. It may also explain how previous exposure could partially account for differences in severity between old vs. young patients


Showing results

110 of 4595

close
1.38862